Background Image:


Our nation’s number one priority should be to beat COVID-19, including supporting the search for much-needed treatments and vaccines. Unfortunately, the administration has pursued a policy that would threaten the very research we need to rid the United States and the world of this pandemic. The proposal is a dangerous and unnecessary distraction to solving the current pandemic. Tell the administration to stop the most favored nation policy immediately.


  • Tell Washington not to Threaten R&D with the IPI Model
  • Tell Lawmakers to Protect Innovation When Addressing Health Care Costs

Tell The Administration: Stop Putting COVID-19 Research At Risk

Biopharmaceutical scientists and researchers have been working around the clock to develop new vaccines and medicines to treat and prevent COVID-19, but we aren’t there yet. Despite this, the administration has pursued a policy that puts current and future research at risk.


The most favored nation proposal would allow the government to set the price of medicines based on foreign governments’ decisions – foreign countries where access to innovative therapies is restricted and investment in treatments and cures is lacking. Case in point, nearly 90% of new medicines launched since 2011 are available in the United States compared to just 50% on average in these other foreign countries. This policy hurts Americans, especially seniors, when we should be helping all Americans stay healthy and get the economy going again. It is a step backwards for the United States when our nation should be doing everything it can to beat COVID-19.


Now more than ever, we need policies that support the development of new medicines, not policies like the most favored nation proposal that will upend medical research and innovation in the United States. Tell the administration to stop this policy immediately so we can get back to focusing on finding treatments and vaccines for COVID-19.

Tell The Administration: Stop Putting COVID-19 Research At Risk

Lupus patient Addy
Mother of 4 Amy

Background Image:


Voters For Cures

The next medical breakthrough is more than just science. It’s personal. Voters for Cures is a leading voice for patients, their families and the health care professionals who understand what’s at stake if policies do not support patient affordability and access, as well as continued medical innovation. Our efforts focus on three core areas:


Strong IP Protections Lead To Stronger Treatments For All

What’s so important about intellectual property rights, or IP for short? Robust IP protections spur innovation, increase competition and lead to more effective treatments and cures for every patient — whether they’re battling cancer, heart disease or COVID-19.

Learn more about the importance of IP protections in the innovation ecosystem.

Patient Voices, Policy Solutions & Cutting-Edge Research

The following articles share policy solutions, exciting R&D progress, and advocate spotlights where patients and those that care for them share the reasons why they vote for cures.